Bolt Biotherapeutics (BOLT) Selling, General & Administrative (2020 - 2026)
Bolt Biotherapeutics (BOLT) posted Selling, General & Administrative of $2.42 million for Q2 2026, down 31.1% from $3.52 million a year earlier and down 13.4% from the prior quarter.
Powered by 
Analysis
Bolt Biotherapeutics (BOLT) Selling, General & Administrative (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Bolt Biotherapeutics was $11.67 million, down 22.6% year-over-year; for FY2025, it was $13.8 million, down 25.3% from FY2024.
- Annual Selling, General & Administrative has declined for three consecutive years, though with a five-year compound annual growth rate of 8.8% (FY2020 to FY2025).
- In prior years, Bolt Biotherapeutics' Selling, General & Administrative was $18.46 million in FY2024 (-18.1%), $22.53 million in FY2023 (-1.7%), $22.93 million in FY2022 (+24.7%) and $18.39 million in FY2021 (+103.1%).
- The Q2 2026 figure stands as the lowest quarterly Selling, General & Administrative since Q4 2020.
- On a year-over-year basis, Selling, General & Administrative has declined in each of the last nine quarters, with an average decline of 27.0% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2021, with growth of 147.8%; the weakest was Q1 2025, with a decline of 34.5%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $2.8 million (Q1 2026), $3.12 million (Q4 2025) and $3.34 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Bolt Biotherapeutics | 6.70 Mn | 6.70 Mn | - | 2.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.42 Mn |
| Mar 31, 2026 | 2.80 Mn |
| Dec 31, 2025 | 3.12 Mn |
| Sep 30, 2025 | 3.34 Mn |
| Jun 30, 2025 | 3.52 Mn |
| Mar 31, 2025 | 3.83 Mn |
| Dec 31, 2024 | 3.95 Mn |
| Sep 30, 2024 | 3.80 Mn |
| Jun 30, 2024 | 4.87 Mn |
| Mar 31, 2024 | 5.84 Mn |
| Dec 31, 2023 | 5.53 Mn |
| Sep 30, 2023 | 5.76 Mn |
| Jun 30, 2023 | 5.62 Mn |
| Mar 31, 2023 | 5.62 Mn |
| Dec 31, 2022 | 5.61 Mn |
| Sep 30, 2022 | 5.49 Mn |
| Jun 30, 2022 | 5.53 Mn |
| Mar 31, 2022 | 6.30 Mn |
| Dec 31, 2021 | 5.10 Mn |
| Sep 30, 2021 | 4.94 Mn |
API Access
Bolt Biotherapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BOLT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "BOLT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BOLT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();